F10 and atrial fibrillation: Idraparinux is a long-acting subcutaneous factor Xa inhibitor that was compared with warfarin in the comparison of idraparinux with vitamin K antagonists for prevention of atrial fibrillation (AMADEUS) trial in patients with non-valvular atrial fibrillation [25].